Back to News
investment

Abingdon Health Plc (ABDXF) Q2 2026 Earnings Call Transcript

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
Abingdon Health reported Q2 2026 half-year results for the period ending December 31, 2025, led by Executive Chairman Chris Hand, a 30-year diagnostics veteran and company co-founder. Leadership shifts include Hand’s transition to Executive Chairman, allowing co-founder Chris Yates to focus on U.S. expansion and global commercial growth, signaling strategic prioritization of international markets. CFO Tom Hayes, appointed over a year ago, highlighted financial performance but provided no specific revenue or profit figures in the transcript excerpt, emphasizing operational updates over detailed financials. The company specializes in rapid lateral flow testing, leveraging Hand’s expertise from prior roles, including drug abuse testing at Cozart, to drive innovation in point-of-care diagnostics. Investor engagement included a live Q&A with deferred responses for unanswered questions, published later via the Investor Meet platform, reflecting transparency but controlled disclosure practices.
AI Audio Summary
0:00 / 0:00
Click to play
634ac7ee-9589-4c49-958b-238f62ca6c02.jpeg
Quantum News · Media Library

SA Transcripts159.02K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Abingdon Health Plc (ABDXF) Q2 2026 Earnings Call March 17, 2026 7:00 AM EDT Company Participants Christopher Hand - Executive ChairmanThomas Hayes - Secretary, CFO & Director Conference Call Participants Paul McManus - Walbrook PR Limited Presentation Operator Good morning, ladies and gentlemen, and welcome to the Abingdon Health plc Half Year Results Investor Presentation. [Operator Instructions] The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and we'll publish our responses where it's appropriate to do so on the Investor Meet company platform. Before we begin, we would like to submit the following poll. And if you'd give that your kind attention, I'm sure the company would be most grateful. And I would now like to hand you over to Executive Chairman, Chris Hand. Chris, good morning, sir. Christopher HandExecutive Chairman Good morning, and good morning, everyone. Thank you for joining this half year results presentation of Abingdon Health. These are the results to the 31st of December '25. So I'm Chris Hand. I'm one of the founders of Abingdon Health and Executive Chairman, a role I took up about a year ago to allow my Co-Founder, Chris Yates, to focus on our global commercial activities and our U.S.A. expansion. My background is in medical diagnostics, 30 years plus in medical diagnostics and specifically rapid testing, which I did both within Abingdon and previously at a company called Cozart, where we specialized in drugs abuse testing using lateral flow. I'm joined today by my colleague, Tom Hayes, who's CFO. Thomas HayesSecretary, CFO & Director Thanks, Chris. So good morning, everyone. So I'm Tom Hayes. I joined Abingdon Health just over 12 months ago now as Chief Financial Officer. Previously, I was Group Finance Director for

Read Original

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.